Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/25/24 16:25 | 10/23/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Levine Mark S. | NY | O | GC | 3 | S | -316 | 30.06 | 0 | -11 | 330 | D | |||||||||||||||
10/25/24 16:23 | 10/23/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Geffner Michael | NY | O | Chief Me | 1 | S | -94 | 29.53 | 0 | -3 | 135 | D | |||||||||||||||
10/25/24 16:21 | 10/23/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NY | O | CTO | 1 | S | -81 | 29.53 | 0 | -3 | 142 | D | |||||||||||||||
10/18/24 16:31 | 10/16/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Salzmann Peter | NY | DO | CEO | 3 | S | -874 | 30.53 | 0 | -29 | 1,008 | D | |||||||||||||||
10/18/24 16:30 | 10/16/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | 2 | S | -188 | 30.28 | 0 | -6 | 368 | D | |||||||||||||||
10/18/24 16:27 | 10/16/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Barnett Eva Renee | NY | O | CFO | 3 | S | -367 | 30.06 | 0 | -12 | 344 | D | |||||||||||||||
8/23/24 16:10 | 8/21/24 | IMVT | Health | BioPrd | Biological Products, (No Diag | Butchko Julia G. | NY | O | Chief De | 1 | S | -96 | 31.86 | 0 | -3 | 441 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |